ACHE and Alzheimer disease: Because of the existence of feedback mechanisms in biological systems, enzyme inhibition may not be able to decrease activity in long term, but instead, may result in increased activity, as reported from the use of rapid-reversible AChE inhibitors that significantly increased both protein activity and expression levels in the CSF of AD patients after long-term treatment (Darreh-Shori and Soininen, 2010).